Thalassemia
Showing 1 - 25 of 104
Cognitive Function and Quality of Life in Thalassemic Children
Not yet recruiting
- Thalassemia
- Pediatric Quality of Life Inventory (questionnaire) and The Stanford-Binet Intelligence Scale fifth edition
-
Sohag, EgyptSohag university Hospital
Sep 25, 2023
Quality of Life in Thalassemic Patients at Assiut University
Not yet recruiting
- Thalassemia
- Abdominal ultrasound
- (no location specified)
Mar 17, 2023
Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)
Recruiting
- Sickle Cell Disease
- +2 more
- Fludarabine
- +7 more
-
Basking Ridge, New Jersey
- +5 more
Feb 17, 2023
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)
Recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Nashville, Tennessee
- +5 more
Feb 2, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)
Active, not recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Stanford, California
- +11 more
Nov 30, 2022
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
Atrial Fibrillation in Beta-Thalassemia
Not yet recruiting
- Atrial Fibrillation
- Thalassemia
-
Ferrara, ItalyMatteo Bertini
Aug 18, 2022
Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))
Active, not recruiting
- Thalassemia
- Luspatercept
- +2 more
-
Los Angeles, California
- +16 more
Aug 16, 2022
Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)
Recruiting
- Thalassemia
- Iron Overload
- CN128 Tablets
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital Of Guangxi Medical University
Aug 3, 2022
Thalassemia, Iron Overload Trial in Nanning (CN128 Tablets)
Active, not recruiting
- Thalassemia
- Iron Overload
- CN128 Tablets
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital Of Guangxi Medical University
Aug 3, 2022
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)
Completed
- Hemoglobinopathies
- +3 more
- Hemoglobinopathy Nursing Program
-
Banhā, Other, EgyptBenha University
May 21, 2022
Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)
Recruiting
- Sickle Cell Disease
- +4 more
- Blood and Marrow Transplant
-
Minneapolis, MinnesotaMasonic Caner Center at University of Minnesota
May 23, 2022
Thalassemia, Iron Overload Trial in Salaya (Meal matrix with polyphenol supplement (PPS), Meal matrix with , No meal matrix with
Not yet recruiting
- Thalassemia
- Iron Overload
- Meal matrix with polyphenol supplement (PPS)
- +3 more
-
Salaya, ThailandMahidol University
Apr 13, 2022
Thalassemia Trial in Peshawar (Thalidomide and Hydroxyurea)
Completed
- Thalassemia
- Thalidomide and Hydroxyurea
-
Peshawar, Khyber Pakhtukhwa, PakistanBlood Diseases Clinic
Mar 10, 2022
Red Blood Cell - IMProving trAnsfusions for Chronically
Recruiting
- Sickle Cell Disease
- +2 more
- Red Blood Cell (RBC) Transfusion
-
Oakland, California
- +13 more
Mar 18, 2022
Sickle Cell Disease, Thalassemia Trial in Memphis (Hydroxyurea, Hydroxyurea Oral Capsule)
Terminated
- Sickle Cell Disease
- Thalassemia
- Hydroxyurea
- Hydroxyurea Oral Capsule
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 18, 2022
Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem
Active, not recruiting
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
Clofarabine and Fludarabine Drug Exposure in Pediatric Bone
Completed
- Hematologic Malignancies
- +7 more
- Clofarabine
- Fludarabine Injection
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell
Completed
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Fludarabine Drug Exposure in Pediatric Bone Marrow
Completed
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021